GB2287709A - Silylated azetidinone intermediates - Google Patents
Silylated azetidinone intermediates Download PDFInfo
- Publication number
- GB2287709A GB2287709A GB9406073A GB9406073A GB2287709A GB 2287709 A GB2287709 A GB 2287709A GB 9406073 A GB9406073 A GB 9406073A GB 9406073 A GB9406073 A GB 9406073A GB 2287709 A GB2287709 A GB 2287709A
- Authority
- GB
- United Kingdom
- Prior art keywords
- formula
- compound
- solution
- reaction
- trialkylsilyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- MNFORVFSTILPAW-UHFFFAOYSA-N azetidin-2-one Chemical compound O=C1CCN1 MNFORVFSTILPAW-UHFFFAOYSA-N 0.000 title claims abstract description 13
- 239000000543 intermediate Substances 0.000 title description 11
- 150000001875 compounds Chemical class 0.000 claims abstract description 28
- 125000004665 trialkylsilyl group Chemical group 0.000 claims abstract description 14
- 238000000034 method Methods 0.000 claims abstract description 10
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 7
- 239000000010 aprotic solvent Substances 0.000 claims abstract description 6
- 238000002360 preparation method Methods 0.000 claims abstract description 5
- -1 enol ester Chemical class 0.000 claims abstract description 4
- 239000003054 catalyst Substances 0.000 claims abstract description 3
- 238000006243 chemical reaction Methods 0.000 claims description 18
- 229910021627 Tin(IV) chloride Inorganic materials 0.000 claims description 9
- HPGGPRDJHPYFRM-UHFFFAOYSA-J tin(iv) chloride Chemical compound Cl[Sn](Cl)(Cl)Cl HPGGPRDJHPYFRM-UHFFFAOYSA-J 0.000 claims description 9
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 5
- 239000001257 hydrogen Substances 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- 150000005826 halohydrocarbons Chemical group 0.000 claims description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 31
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 26
- 239000000243 solution Substances 0.000 description 19
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 18
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 17
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 15
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 13
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 12
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 8
- 150000002084 enol ethers Chemical class 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 6
- JHIVVAPYMSGYDF-PTQBSOBMSA-N cyclohexanone Chemical class O=[13C]1CCCCC1 JHIVVAPYMSGYDF-PTQBSOBMSA-N 0.000 description 6
- 235000017557 sodium bicarbonate Nutrition 0.000 description 6
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 6
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 5
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 5
- 239000003208 petroleum Substances 0.000 description 5
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 5
- 238000005160 1H NMR spectroscopy Methods 0.000 description 4
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- 239000012267 brine Substances 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 239000010410 layer Substances 0.000 description 4
- PYLWMHQQBFSUBP-UHFFFAOYSA-N monofluorobenzene Chemical compound FC1=CC=CC=C1 PYLWMHQQBFSUBP-UHFFFAOYSA-N 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 239000012047 saturated solution Substances 0.000 description 4
- 229910052938 sodium sulfate Inorganic materials 0.000 description 4
- 235000011152 sodium sulphate Nutrition 0.000 description 4
- AKEJUJNQAAGONA-UHFFFAOYSA-N sulfur trioxide Chemical compound O=S(=O)=O AKEJUJNQAAGONA-UHFFFAOYSA-N 0.000 description 4
- 101150041968 CDC13 gene Proteins 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 3
- FTVLMFQEYACZNP-UHFFFAOYSA-N trimethylsilyl trifluoromethanesulfonate Chemical compound C[Si](C)(C)OS(=O)(=O)C(F)(F)F FTVLMFQEYACZNP-UHFFFAOYSA-N 0.000 description 3
- JYJURPHZXCLFDX-ZETCQYMHSA-N (2s)-2-methoxycyclohexan-1-one Chemical compound CO[C@H]1CCCCC1=O JYJURPHZXCLFDX-ZETCQYMHSA-N 0.000 description 2
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 239000007832 Na2SO4 Substances 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- 229960001760 dimethyl sulfoxide Drugs 0.000 description 2
- QQFBQBDINHJDMN-UHFFFAOYSA-N ethyl 2-trimethylsilylacetate Chemical compound CCOC(=O)C[Si](C)(C)C QQFBQBDINHJDMN-UHFFFAOYSA-N 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 description 2
- LJCNRYVRMXRIQR-OLXYHTOASA-L potassium sodium L-tartrate Chemical compound [Na+].[K+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O LJCNRYVRMXRIQR-OLXYHTOASA-L 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- JVBXVOWTABLYPX-UHFFFAOYSA-L sodium dithionite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])=O JVBXVOWTABLYPX-UHFFFAOYSA-L 0.000 description 2
- 235000011006 sodium potassium tartrate Nutrition 0.000 description 2
- 235000011149 sulphuric acid Nutrition 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- DCQQZLGQRIVCNH-RNFRBKRXSA-N (1r,2r)-2-methoxycyclohexan-1-ol Chemical compound CO[C@@H]1CCCC[C@H]1O DCQQZLGQRIVCNH-RNFRBKRXSA-N 0.000 description 1
- VFSJVWDGYZBAHH-UHFFFAOYSA-N (6-methoxycyclohexen-1-yl)oxy-trimethylsilane Chemical compound COC1CCCC=C1O[Si](C)(C)C VFSJVWDGYZBAHH-UHFFFAOYSA-N 0.000 description 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- QMMFVYPAHWMCMS-UHFFFAOYSA-N Dimethyl sulfide Chemical compound CSC QMMFVYPAHWMCMS-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000003810 Jones reagent Substances 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 1
- 241001661345 Moesziomyces antarcticus Species 0.000 description 1
- 108010084311 Novozyme 435 Proteins 0.000 description 1
- QYTDEUPAUMOIOP-UHFFFAOYSA-N TEMPO Chemical group CC1(C)CCCC(C)(C)N1[O] QYTDEUPAUMOIOP-UHFFFAOYSA-N 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- VFSJVWDGYZBAHH-VIFPVBQESA-N [(6s)-6-methoxycyclohexen-1-yl]oxy-trimethylsilane Chemical compound CO[C@H]1CCCC=C1O[Si](C)(C)C VFSJVWDGYZBAHH-VIFPVBQESA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 description 1
- 229940117975 chromium trioxide Drugs 0.000 description 1
- GAMDZJFZMJECOS-UHFFFAOYSA-N chromium(6+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[Cr+6] GAMDZJFZMJECOS-UHFFFAOYSA-N 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 150000001934 cyclohexanes Chemical class 0.000 description 1
- IEJIGPNLZYLLBP-UHFFFAOYSA-N dimethyl carbonate Chemical compound COC(=O)OC IEJIGPNLZYLLBP-UHFFFAOYSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000002024 ethyl acetate extract Substances 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- PZEKPKZYFANHRD-UHFFFAOYSA-N n-bromoacetamide;1,3-dibromo-5,5-dimethylimidazolidine-2,4-dione Chemical compound CC(=O)NBr.CC1(C)N(Br)C(=O)N(Br)C1=O PZEKPKZYFANHRD-UHFFFAOYSA-N 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 150000007530 organic bases Chemical group 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 235000003270 potassium fluoride Nutrition 0.000 description 1
- 239000011698 potassium fluoride Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000003579 shift reagent Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000012258 stirred mixture Substances 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- JRMUNVKIHCOMHV-UHFFFAOYSA-M tetrabutylammonium bromide Chemical compound [Br-].CCCC[N+](CCCC)(CCCC)CCCC JRMUNVKIHCOMHV-UHFFFAOYSA-M 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
- C07F7/1872—Preparation; Treatments not provided for in C07F7/20
- C07F7/1892—Preparation; Treatments not provided for in C07F7/20 by reactions not provided for in C07F7/1876 - C07F7/1888
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
Abstract
A process for the preparation of a compound of formula (I) wherein R1 is a trialkylsilyl group and R2 is a hydrogen atom or a trialkylsilyl group <IMAGE> which comprises reacting the azetidinone (II) with the homochiral enol ester (III> <IMAGE> in an aprotic solvent in the presence of a slannic catalyst.n
Description
Chemical Process
The present invention relates to an improved process for the preparation of an intermediate useful in the preparation of antibacterial agents.
European Patent Application, publication No. 041 6953A2 describes a novel class of tricyclic antibacterial agents. A particularly preferred compound described and claimed therein is the compound (A)
and salts thereof.
A key intermediate in the synthesis of compound (A) is the methoxy ketone (B).
wherein R1 is a hydroxyl protecting group such as trialkylsilyl group e.g. tbulydimethylsilyl. The present invention provides an improved process for preparing the intermediates of formula (B) with a high degree of enantiomeric purity.
Thus the present invention provides a process for the preparation of compounds of formula (I)
wherein R1 is a trialkylsilyl group and R2 is a hydrogen atom or a trialkysilyl group which comprises reaction of the azetidinone (II) wherein R1 is defined in formula (I) and R2 is a trialkysilyl group
with the homochiral enol ether (III)
wherein R3 is a trialkylsilyl group. The reaction is carried out in an aprotic solvent such as halohydrocarbon e.g. dichloromethane, chlorobenzene or fluorobenzene, acetonitrile or a hydrocarbon e.g. toluene in the presence of a suitable catalyst such as stannic chloride stannic chloride etherate or stannic chloride dimethylsulphide complex and preferably at a temperature within the range -15 to 300 e.g. -15 to 250 and when desired or necessary subsequent conversion of the compound of formula (I) wherein R2 is trialkylsilyl into the corresponding compound of formula (I) wherein R2 is hydrogen.
The trialkylsilyl groups R1, R2 and R3 are preferably tri(C1 4)alkyl groups.
Examples of suitable trialkylsilyl groups include trimethylsilyl and tbutyldimethylsilyl.
A preferred azetidinone (II) for use in the reaction is that wherein R1 is tbutyldimethysilyl and R2 is trimethylsilyl.
A preferred chiral enol ether (III) is that wherein R3 is trimethylsilyl.
The interconversion of a compound of formula (I) wherein R2 is trialkylsilyl into a compound of formula (I) wherein R2 is hydrogen may be carried using conventional methods known for carrying out such reactions. Thus compounds wherein R2 is hydrogen may be prepared from compounds wherein R2 is trimethylsilyl by reaction with acetic acid and tetrabutylammonium fluoride in an aprotic solvent such as tetrahydrofuran or by reaction with trifluoroacetic acid.
The homochiral enol ethers (III) are novel compounds and represent a further aspect of the present invention.
The homochiral enol ether (III) may conveniently be prepared from the homochiral cyclohexanone derivative (IV).
by reaction with an appropriate O-silylating agent. Examples of suitable 0silylating agents include ethyl trimethylsilylacetate or trimethylsilyl trifluoromethylsulphonate.
The reaction of the cyclohexanone derivative (IV) with ethyl trimethylsilylacetate is preferably carried out in the presence of tetrabutylammonium fluoride on silica gel and in a solvent such as an ether e.g. tetrahydrofuran and at a temperature within the range -78-00 e.g. -400.
The reaction of the cyclohexane derivative (IV) with trimethylsilyl trifluoromethylsulphonate is preferably carried out in the presence of a tertiary organic base such as triethylamine and in an aprotic solvent such as dichlormethane.
The cyclohexanone derivative (Ill) may be prepared by oxidation of the homochiral hydroxy ether (V)
using conventional procedures. Thus for example the oxidation may be carried out using oxalyl chloride and dimethylsulphoxide, pyridine/sulphur trioxide, sodium hyprochlorite/2,2,6,6-tetramethyl-1 -piperidinyloxy, N-bromacetamide 1 ,3-dibromo-5,5-dimethylhydantoin or Jones reagent (CrO3/H2SO4). The reaction is conveniently carried out in a solvent, the choice of which will depend upon the oxidants to be used. Thus oxidation using oxalylchloride and dimethylsulphoxide is conveniently carried out in a halohydrocarbon e.g.
dichloromethane and at a temperature within the range -780-500. Oxidation using pyridine and sulphur trioxide is conveniently carried out in a solvent such as an ether e.g. t-butylmethyl ether and in the presence of acetone and a base such as triethylamine or diisopyropylethylamine.
The homochiral hydroxyether (V) is a known compound and may be prepared using known procedures such as those described by . Honig H, Senfer
Wassenthal P, Synthesis 1990, 1137-1140 Laumen K et al, J Chem. Soc.,
Chem. Commun., 1989, 148-150 or Peterson et al, Jorg. Chem, 1988, 53 19031907 or more preferably by the prodedure described herein below in
Intermediate 1.
In order that the invention may be more fully understood the following examples are given by way of illustration only.
Intermediate 1 (1 S.2S)-2-methoxycyclohexanol
Immobilised Candida antarctica lipase (Novozyme 435;10g) was added to a solution of (+) trans-2-methoxycyclohexanol (50g), vinyl acetate (42ml) and triethylamine (6ml) in cyclohexane (167ml). The mixture was stirred in a stoppered conical flask for 24h at room temperature and then filtered through a number 3 sinter funnel under vacuum. The filter cake was washed with cyclohexane (100ml). The filtrate (350ml) was taken and vigourously extracted with water (4 x 180ml). The combined water extracts (820ml) were back extracted with cyclohexane (200ml). The water layer was taken and sodium chloride (245g to give 5M) added. After dissolution, the salt solution (ca 900ml) was extracted with ethyl acetate (2 x 450ml) and the combined ethyl acetate extracts were reduced in vacuo to afford the title product as a pale yellow oil (17.5g ee > 99%).
Intermediate 2 (2S)-2-methoxycyclohexanone
Concentrated sulphuric acid (6.1 ml) was added to a solution of chromium trioxide (7 g) in water (50ml) cooled to 00. An aliquot of this solution (30ml) was added dropwise over a few minutes to a solution of (1 S,2S)-1-methoxy cyclohexanol (1.95 g) in dichloromethane (15ml) cooled to 00. The solution was vigorously stirred at 0 for 1 h and then quenched by addition of of isopropyi alcohol (2.5 ml). The mixture was extracted with dichloromethane (3x50ml); the combined extracts were washed with a saturated solution sodium bicarbonate (30ml), then with brine (50ml) and dried. The mixture was then filtered over celite; the solution was evaporated under reduced pressure at room temperature to give the title compound as a pale yellow liquid ( yield=56%, e.e.=1 00%).
1 H-NMR(400 MHz; CDC13): 3.68(m,1 H);3.40(s,3H); 2.50(m,1 H);2.22 2.18(m,2H);2.0-1 .8(m,2H);1.6(m,3H).
Intermediate 3 (3S.4R)-1 -(tnmethvlsilvl)-4-acetoxy-3((R)-(t- butyldim ethylsilylxoy)ethyl]azetidine-2-one Triethylamine (5.4ml) and trimethylsilylchloride (4.3ml) were added to a solution of (3S,4R)-4-acetoxy-3((R)-(t-butyldimethylsilyloxy)ethyl]-2-azetidi none (7.5g) in dry tetrahydrofuran (60ml) and the mixture stirred at room temperature for 1 hr.
The reaction mixture was filtered twice on a sintered glass filter under nitrogen and the filtrate concentrated under reduced pressure to give the title compound in 99% yield.
Example 1 (3 S)-3-meth oxy-2-trim ethylsiloxycyclohex-1 -ene
To a cooled (-300C) solution of triethylamine (8.4ml) in dry dichloromethane (60ml) under nitrogen, trimethylsilyl trifluoromethylsulphonate (10.2ml) was added. (2S)-2-Methoxycyclohexanone (6g) was added, the mixture was stirred at -300C for 2 hours, and hexane (ca. 3 volumes) was then added. The hexane phase was separated from the oil which precipitated out, concentrated under vacuum and the residue was filtered on a short alumina pad eluting with petroleum ether to give the title compound as a colourless oil (5.5g).
e.e + 86% (shift reagent: trisC3-(trifluoroacetyl-d-camphorate)l Eu(lll), CDCI3) [alD 74.60 (nm = 589, c=2.005, 1=10cm, CH2CI2) 1H-NMR (400 MHz; CDC13) 4.97(1H,dd); 3.49(1H,m); 3.40(3H,s); 2.141.84(3H,m); 1.70-1.44(3H,m); 0.20-0.11 (9H,s).
Example 2 (3S.4R)-3-[(R)-1 -(t-butyldimethylsilyloxy)ethyl]-4t(R)-2'-((S)-61m ethoxy-1 - oxocyclohexyl)azetidine-2-one To a solution of intermediate 3 (9.49) and the compound of Example 1 (139) in an hydros dichloromethane (50ml) was added dropwise a preformed solution of stannic chloride etherate (6.1 ml) in dry dichloromethane (80ml) (over 20 mins) keeping the reaction flask in a water bath at room temperature.The bright yellow solution was stirred for an additional 10 mins, poured into a stirred ice-cold saturated solution of sodium hydrogen carbonate (800ml) and diluted with diethyl ether (500ml). The mixture was filtered on a Celite pad and then extracted twice with diethyl ether (2x500ml). The combined organic extracts were washed with brine, then dried over sodium sulphate and evaporated under vacuum. The resulting yellow oil was dissolved in distilled tetrahydrofuran (150ml), then acetic acid (0.9eq.) and tetrabutylammonium fluoride (0.9eq. from 1.1 M soln. in tetrahydrofuran) were added and the reaction stirred under nitrogen for one hour. The reaction was then poured into a saturated solution of sodium hydrogen carbonate (150ml) and extracted with diethyl ether (2x100ml).
The organic layer was washed with ice cold hydrochloride acid (2% soln.), then with a saturated solution of sodium hydrogen carbonate, and finally brine. The organic phase washed and evaporation of the solvent afforded an oil (ca. 1 3g).
The residue was dissolved into acetonitrile (80ml). The white solid which precipitated was filtered off. Acetonitrile (15ml) and water (5ml) were added to the filtrate, which was extracted with cyclohexane (2x15ml). Evaporation of the acetonitrile afforded an oil which was filtered through a silica pad (50g) eluting with petroleum ether (2 1) and then diethyl ether/petroleum ether 1/1(2 1). The elutant was concentrated and the residue crystallised from petroleum ether to give the title compound (2.19). The mother liquors were filtrered on a silica pad, concentrated and the residue crystallized from petroleum ether to give additional 500mg of the title compound.
Example 3 (3S .4R)-3-f(R)-1 -(t-butyldimethylsilyloxy)ethyl]-4[(R )-2'-(S)-6'-methoxy-1 'oxocyclohexyl)azetidin-2-one
Tin tetrachloride (0.86ml) was added to dry fluorobenzene (20ml), under a nitrogen atmosphere. The solution was cooled to -6 C, then a solution of intermediate 3 (1.2g) in dry fluorobenzene (14ml) was added over 15 minutes.The mixture was stirred for 5 min at 0 C, then a solution of (-)-3 methoxy-2-tri methylsilyloxycyclohex-1 -ene (1.4ml) in i n dry fluorobenzene (1 4ml) was added over 30 minutes. The reaction was stirred at 0 C for further 7 minutes and then poured into a mixture of Rochelle salt (100ml), saturated sodium hydrogen carbonate solution (100ml) and ethyl acetate (200ml). The mixture was stirred for 20 minutes, then the layers were separated. The aqueous layer was extracted with further ethyl acetate (100ml). The combined organic extracts were washed with brine (50ml), dried (Na2SO4) and concentrated in vacuo to give an oil (1.9g).
This material was dissolved in dichloromethane (24ml) and treated with potassium fluoride (0.29), tetrabutyl ammonium bromide (1.lg) and acetic acid (0.2ml). The suspension was stirred at 23"C for 30 minutes, then a satured sodium hydrogen carbonate solution (50my) was added and the mixture was stirred for 30 minutes. The layers were separated; the organic layer was washed with water (2x50ml), dried (Na2SO4) and concentrated in vacuo to give the crude title compound (1.859) as a white solid.
A portion (1.579) was crystallized from n-hexane to give the title compound as a white solid (0.729).
1H-NMR (CDC13): 5.76 (s, 1H); 4.18 (m, 1H); 3.99 (m,1H); 3.57 (t, 1H); 3.27 (s, 3H); 3.09 (m, 1 H); 2.88 (dd, 1 H); 2.23 (m, 1 H); 2.09(m, 1 H); 1.99 (m, 1 H); 1.771.5 (m, 3H); 1.24 (d, 3H); 0.87 (s, 9H); 0.07 (s, 3H); 0.06 (s, 3H).
Example 4 (3S .4R)-3-[(R)-I -(t-butyidimethylsilyloxy)ethyl]-4ttR)-2'-(S!-6'-methoXv^1 '- oxocyclohexyl)azetidin-2-one To a stirred solution of tin tetrachloride (6.5ml) in dry dichloromethane (80 ml) at 0 C under nitrogen was added dry dimethylsulphide (8.2 ml) over 5 minutes. The resulting solution was stirred for 5 minutes before being allowed to reach room temperature. To the reaction flask was introduced a solution of Intermediate 3 (10g) and Example 1 (16 ml) in dry dichloromethane (100 ml) dropwise over 1 h. The reaction mixture was then stirred for a further 1.5 h before pouring into a stirred mixture of saturated aqueous NaHCO3 (500 ml) and saturated aqueous Rochelle's salt (500 ml) and ethyl acetate (600 ml). After 20 min, the aqueous phase was washed with ethyl acetate (3 x 200 ml) and the combined organic phases were washed with saturated brine (400 ml), dried over an hydros sodium sulphate (2009), filtered and the solvents removed under reduced pressure. The resulting viscous oil was dissolved in ethanol (50 ml) and treated with vegetable charcoal (3.9 g) at reflux for 45 min. After filtration under reduced pressure, the solvent was evaporated to give a crude foam (11 g) which was dissolved in hot n-hexane (20ml), allowed to reach room temperature and seeded with a few crystals of the title compound before standing at 40C for 6 h. The resulting precipitate was filtered
washed with cold hexane (3 x 20 ml) and dried under vacuum to afford the title compound (2.8 g) as an off-white solid.
The mother liquors were evaporated to give a foam (8 g) which was dissolved in nhexane (20 ml) and filtered through a pad of silica gel (16 g in a pad 9 cm high).
The pad was then washed with separate aliquots of n-hexane (10 x 50 ml) and then 50 : 1 n-hexane : ethyl acetate (3 x 200 ml). The filtrate fractions collected containing the desired product (TLC) were evaporated to dryness to give title compound as a colourless solid (1.4 g).
1H-NMR(400 MHZ);CDCl3) 5.75(1H sa);4.18(1H m), 3.99(1H m); 3.57(1H t); 3.28(3H s); 3.10(1H m); 2.88(1H dd); 2.24(1H m); 2.09(1H m); 1.99(1H m); 1.71.5(3H m); 1.24(3H d); 0.87(3H s); 0.08 (3H s); 0.06(3H s).
Claims (5)
- ClaimsA process for the preparation of a compound of formula (I) wherein R, is a trialkylsilyl group and R2 is a hydrogen atom or a trialkylsilyl groupwhich comprises reacting the azetidinone (II) wherein R1 is as defined in formula (I) and R2 is a trialkylsilyl groupwith the homochiral enol ester (III) wherein R3 is a trialkylsilyl groupin an aprotic solvent and in the presence of a catalyst selected from stannic chloride, stannic chloride etherate or a stannic chloride dimethylsulphide complex, followed when desired or necessary by the subsequent conversion of a compound of formula (I) wherein R2 is trialkylsilyl into the corresponding compound of formula (I) wherein R2 is hydrogen.
- 2. A process as claimed in claim 1 wherein the aprotic solvent is a halohydrocarbon.
- 3. A process as claimed in claim 1 or claim 2 wherein the reaction is carried out at a temperature within the range -15" to 300.
- 4. A process as claimed in any of claims 1 to 3 wherein R1 is a tbutyldimethylsilyl group and R2 and R3 each represent a trimethylsilyl group.
- 5. A compound of formula (I), as defined in claim 1 whenever prepared by a process as claimed in any of claims 1 to 4.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9406073A GB2287709A (en) | 1994-03-26 | 1994-03-26 | Silylated azetidinone intermediates |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9406073A GB2287709A (en) | 1994-03-26 | 1994-03-26 | Silylated azetidinone intermediates |
Publications (2)
Publication Number | Publication Date |
---|---|
GB9406073D0 GB9406073D0 (en) | 1994-05-18 |
GB2287709A true GB2287709A (en) | 1995-09-27 |
Family
ID=10752599
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB9406073A Withdrawn GB2287709A (en) | 1994-03-26 | 1994-03-26 | Silylated azetidinone intermediates |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2287709A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0847989A1 (en) * | 1996-12-12 | 1998-06-17 | Takasago International Corporation | Process for producing cyclohexylazetidinone |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0416952A2 (en) * | 1989-09-08 | 1991-03-13 | GLAXO S.p.A. | 4-(1'-Oxocyclohex-2'-yl)azetidin-2-one derivatives |
-
1994
- 1994-03-26 GB GB9406073A patent/GB2287709A/en not_active Withdrawn
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0416952A2 (en) * | 1989-09-08 | 1991-03-13 | GLAXO S.p.A. | 4-(1'-Oxocyclohex-2'-yl)azetidin-2-one derivatives |
Non-Patent Citations (1)
Title |
---|
J.Chem. Soc., Chem. Commun., (4), 441-2, (1994). * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0847989A1 (en) * | 1996-12-12 | 1998-06-17 | Takasago International Corporation | Process for producing cyclohexylazetidinone |
Also Published As
Publication number | Publication date |
---|---|
GB9406073D0 (en) | 1994-05-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0752984B1 (en) | Process for the preparation of cyclohexyl-azetidinones | |
AU2006225205B2 (en) | Process for the manufacture of organic compounds | |
EP0008497B1 (en) | Beta-lactam-containing compounds, their preparation and pharmaceutical compositions containing them | |
AU596606B2 (en) | Azetidin-2-one derivatives and process for production thereof | |
US4596677A (en) | Anhydropenicillin intermediates | |
US4645854A (en) | Process for preparing HMG-CoA reductase inhibitors with a 3,5-dihydroxypentanoate subunit | |
Annunziata et al. | Stereoselective synthesis of 2-azetidinones as cholesterol-absorption inhibitors | |
GB2287709A (en) | Silylated azetidinone intermediates | |
EP0164049A2 (en) | Process for preparing HMG-CoA reductase inhibtors with a 3,5-dihydroxypentanoate subunit | |
EP0180189A2 (en) | Novel beta-lactams and their production | |
AU2001293726B2 (en) | Process for preparing discodermolide and analogues thereof | |
US4511509A (en) | 3-Alkylidine azetidine compound and their production | |
EP0389244A1 (en) | Process for synthesis of FK-506 C10-C18 intermediates | |
US4079055A (en) | Chemical reduction process | |
US4767853A (en) | Synthesis of 1-(allyloxycarbonyl)-methyl-3-(hydroxyethyl)-4-beta-naphthoxythiocarbonylthio-2-azetidinones and hydroxy protected analogs thereof | |
JPH06104672B2 (en) | Penems production method | |
EP0282241B1 (en) | Beta-lactam compounds and production process thereof | |
JPH1017561A (en) | Allyl alcohols and production method thereof | |
JP3059475B2 (en) | Method for producing 2-azetidinone derivative | |
US5155228A (en) | FK-506 C10-C18 process intermediates | |
JPH04230360A (en) | Heterocyclic derivative | |
US4948885A (en) | Synthesis of azetidinones | |
US5053502A (en) | Anhydro penicillin derivatives | |
US5191074A (en) | β-lactam compounds and production process thereof | |
JP3471067B2 (en) | Method for producing optically active 6- (4-substituted inden-1-yl) -2-methyl-4-hepten-3-ols |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |